Stay updated on Danirixin Safety & Efficacy in Adult Influenza Clinical Trial
Sign up to get notified when there's something new on the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page.

Latest updates to the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 was added, and the funding status notice and Revision: v3.4.1 entry were removed.SummaryDifference0.3%

- Check39 days agoChange DetectedThe page now displays a notice about potential updates due to government funding and directs users to current operating status; the revision version was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check46 days agoChange DetectedAdded UI label Show glossary and new metadata entries (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with Revision: v3.4.0. Removed the previous entries Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.1%

- Check60 days agoChange DetectedFooter revision tag updated to v3.3.4, replacing the previous v3.3.3.SummaryDifference0.0%

- Check81 days agoChange DetectedThe Locations section was updated with new regional entries (USA and Australia) and old location blocks removed, in Revision: v3.3.3.SummaryDifference1%

Stay in the know with updates to Danirixin Safety & Efficacy in Adult Influenza Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page.